CHI3L1 and myeloid sarcoma: In the CNS under inflammatory conditions (e.g., MS), CHI3L1 is produced by infiltrating immune cells (e.g., macrophages and neutrophils), endothelial cells, microglia, and astrocytes, rendering it a potential biomarker [45,46].